Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 523 shares at $87.92 ($46K) on 2026-06-17, disclosed to the SEC on 2026-06-17.
Scheduled sale ($46k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |
| EW | SELL | 2025-06-03 | $2.6M | — | Filing → |